Clinical Trial

Safety and Efficacy of OTL78 (Zopocianine)

Name: Safety and Efficacy of OTL78 (Zopocianine) — clinical trial record (NCT07725523)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This study is being done to support the selection of single dose and timing regimen of Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging to improve the detection of malignant (growing in an uncontrolled way) tissue in adult patients undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.

Trial Details

NCT Number	NCT07725523
Lead Sponsor	Clinton Bahler Collaborators: On Target Laboratories, LLC, Indiana University
Conditions	Prostate Cancer Surgery, Prostate Cancer Metastatic Disease
Enrollment	36 participants
Start Date	2026-09
Primary Completion	2027-02 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-07-30